Eloxx Pharmaceuticals, Inc. (ELOX)
OTCMKTS
· Delayed Price · Currency is USD
0.120
0.00 (0.00%)
At close: Apr 29, 2026
Eloxx Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | - | 6.36 | - | - | - | Upgrade
|
| Gross Profit | - | 6.36 | - | - | - | Upgrade
|
| Selling, General & Admin | 3.38 | 5.25 | 8.69 | 11.39 | 20.55 | Upgrade
|
| Research & Development | 3.06 | 3.58 | 8.6 | 23.03 | 21.8 | Upgrade
|
| Operating Expenses | 6.44 | 8.83 | 17.29 | 34.42 | 42.35 | Upgrade
|
| Operating Income | -6.44 | -2.47 | -17.29 | -34.42 | -42.35 | Upgrade
|
| Interest Expense | -1.05 | -1.14 | -1.15 | -1.95 | -1.26 | Upgrade
|
| Interest & Investment Income | 0.03 | 0.03 | 0.25 | 0.27 | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | -0 | 0 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.07 | 0.43 | 1.28 | 0.03 | - | Upgrade
|
| EBT Excluding Unusual Items | -7.39 | -3.16 | -16.91 | -36.07 | -43.6 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -1 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0 | 0.04 | 0.29 | - | - | Upgrade
|
| Other Unusual Items | 1.39 | -0.03 | -0.44 | - | 0.54 | Upgrade
|
| Pretax Income | -6 | -3.14 | -17.05 | -36.07 | -66.73 | Upgrade
|
| Net Income | -6 | -3.14 | -17.05 | -36.07 | -66.73 | Upgrade
|
| Net Income to Common | -6 | -3.14 | -17.05 | -36.07 | -66.73 | Upgrade
|
| Shares Outstanding (Basic) | 12 | 4 | 3 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 12 | 4 | 3 | 2 | 2 | Upgrade
|
| Shares Change (YoY) | 228.49% | 46.22% | 18.66% | 23.86% | 74.36% | Upgrade
|
| EPS (Basic) | -0.49 | -0.84 | -6.63 | -16.65 | -38.15 | Upgrade
|
| EPS (Diluted) | -0.49 | -0.84 | -6.63 | -16.65 | -38.15 | Upgrade
|
| Free Cash Flow | -6.33 | -4.72 | -14.34 | -31.91 | -35.09 | Upgrade
|
| Free Cash Flow Per Share | -0.51 | -1.25 | -5.58 | -14.73 | -20.06 | Upgrade
|
| Gross Margin | - | 100.00% | - | - | - | Upgrade
|
| Operating Margin | - | -38.81% | - | - | - | Upgrade
|
| Profit Margin | - | -49.43% | - | - | - | Upgrade
|
| Free Cash Flow Margin | - | -74.15% | - | - | - | Upgrade
|
| EBITDA | -6.4 | -2.43 | -17.18 | -34.34 | -42.23 | Upgrade
|
| EBITDA Margin | - | -38.26% | - | - | - | Upgrade
|
| D&A For EBITDA | 0.04 | 0.04 | 0.11 | 0.08 | 0.11 | Upgrade
|
| EBIT | -6.44 | -2.47 | -17.29 | -34.42 | -42.35 | Upgrade
|
| EBIT Margin | - | -38.81% | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.